PureHealth reports AED505mln net profit and AED1.1bln EBITDA for first quarter 2025
H.E Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong Q1 2025 results underscore the strength of our integrated healthcare model and the resilience of our long-term strategy. We are redefining healthcare delivery by combining operational excellence with cutting-edge innovation to raise the standard of care across the region and beyond. As we continue to expand our global presence and invest in future-ready medical capabilities, our focus remains clear—delivering superior patient care, creating sustainable value for our shareholders, and making a meaningful, long-term impact on the health and well-being of the communities we serve.'
Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'PureHealth's first quarter results reflect the solid growth witnessed across all core segments. The Group's results for the period came on the back of strong patient volume increases across our hospital network, both locally and internationally, and continued momentum in our insurance division with high renewal rates and expansion into new markets. Our strong operational execution, transformations of the assets, and the synergies between the entities are delivering tangible results, and strengthening the foundation for future growth. As we look ahead, PureHealth is well-positioned to continue expanding our reach, deepening our platform capabilities, and advancing specialised care to meet the evolving needs of the healthcare sector both in the UAE and internationally.'
Financial & Operational Highlights
The Group's positive performance was driven by growth across all segments in Q1-2025. The Hospital segment remained the largest contributor to the Group's top-line at 59%, with revenue growing 3% year-on-year to AED 5.0 billion in Q1 2025. The segment's performance was supported by sustained momentum in patient volumes and strategic investments in expanding both service breadth and geographic reach across PureHealth's UAE and UK assets. On this front, PureHealth recorded over 2.5 million patient interactions during the quarter across its UAE and UK assets, up 9% year-on-year. Additionally, inpatient visits rose by 4% year-on-year to approximately 53,000, while outpatient volumes grew by 9% year-on-year to reach 2.2 million and hospital bed capacity increased 2% year-on-year to 5,500 beds in Q1-2025. The Insurance segment generated AED 1.86 billion in revenue, up 19% year-on-year in Q1-2025. This growth was supported by a 15% year-on-year increase in Gross Written Premiums, reflecting strong renewal rates and expansion into underpenetrated markets. New product launches, as well as a global partnership with AXA for international private medical insurance, helped diversify the portfolio and enhance customer value. Overall, active membership grew to 3.2 million, while over 13.9 million claims were processed in Q1-2025.
The Procurement segment generated revenues of AED 1.2 billion in the first quarter, representing a 11% year-on-year increase compared to the previous year. Growth was largely driven by strengthened partnerships with suppliers, an expanding client base across the UAE and GCC, and an increased share of high-tech medical equipment and specialty pharmaceuticals in the Group's procurement mix.
Revenue from Diagnostic Services increased 14% year-on-year to AED 261 million, driven by a 16% year-on-year increase in testing volumes in Q1-2025. Moreover, further supporting the segment's performance was the integration of Sheikh Shakhbout Medical City (SSMC) into the PureLab network, which contributed over 700,000 additional test volumes. In addition, SEHA clinics continued to scale their laboratory operations, further driving utilisation and strengthening the segment's performance.
The Technology Services segment reported revenue growth of 132% year-on-year to AED 152 million in Q1-2025. This was led by PureCS, PureHealth's dedicated technology company, which made substantial progress in deploying clinical and operational technology across solutions during the period.
Strategic Developments
Following its Annual General Assembly, PureHealth announced a dividend of AED 343 million for FY 2024, its first distribution post-listing on the ADX which represented a 20% payout ratio.
In the UAE, PureHealth continued to strengthen its leadership in healthcare delivery. SEHA advanced its transplant programmes, expanded mental health services, opened new outpatient clinics, and onboarded over 150 specialist physicians to support specialised care. Additionally, SSMC reinforced its cardiac and specialty care footprint through the launch of advanced diagnostic centres, cutting-edge procedures, and new specialty clinics focused on women's and adolescent mental health.
Internationally, Circle Health Group in the UK further established itself as an innovation leader by securing the largest European order of surgical robots, expanding outpatient services with new centres in Cheshire, Inverness, and Glasgow, enhancing physiotherapy capabilities, and advancing oncology care through in-house monoclonal antibody preparation.
Daman launched "Amanak," a new insurance product tailored for employees of small and medium businesses in the Northern Emirates. It also entered into a global partnership with AXA to offer International Private Medical Insurance (IPMI) products, expanding its international reach. In parallel, Daman provided facultative reinsurance offerings, supported by its strong financial position and solid solvency metrics. The company also accelerated initiatives to enhance customer experience, deepen collaboration with government entities, and deploy digital solutions to drive greater operational efficiency.
Our Diagnostics vertical, PureLab, launched the Abu Dhabi Public Health Centre Surveillance Lab in February 2025, specialising in molecular and genomics testing to strengthen public health capabilities. Additionally, PureLab signed an MoU with ExpressMed Diagnostics & Research Bahrain to expand its reach and cater to referral volumes from outside the UAE.
The Group's procurement arm, Rafed, managed the Nationwide Immunisation Programme on behalf of the UAE Government.
Looking ahead, PureHealth remains firmly committed to building a resilient, technology-driven global healthcare platform. By embedding digital intelligence across its integrated ecosystem, PureHealth is redefining healthcare delivery and driving sustainable value. Moreover, the Group is advancing organic growth through service expansion, clinical innovation, and capacity building, while scaling internationally through targeted acquisitions. On this front, PureHealth will accelerate its global expansion strategy through the integration of new assets, including the addition of Hellenic Healthcare Group (HHG) in Europe to the Group's portfolio. Moreover, with a fortified balance sheet following the early repayment of AED 1.85 billion in debt during Q1 2025, PureHealth is well-positioned to reinvest in high-growth opportunities and deliver sustainable value for its stakeholders.
About PureHealth:
PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 110+ hospitals, 316+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world.
PureHealth's network comprises:
SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE
SEHA CLINICS - Delivering comprehensive community-based healthcare services
Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care
The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE
Daman (The National Health Insurance Company) – The UAE's leading health insurer
Rafed – The UAE's largest healthcare Group Purchasing Organisation
PureLab – Managing and operating the largest network of laboratories in the region
One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers
The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment
Ardent Health Services – The fourth largest privately held acute care hospital operator in the US
Circle Health Group – The largest independent operators of hospitals in the UK
Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus
PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
an hour ago
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Zawya
6 hours ago
- Zawya
PureHealth delivers strong H1 2025 results with AED 13.6bln in revenue and AED 1.03bln in net profit
Abu Dhabi – PureHealth Holding PJSC ('PureHealth' or 'the Group') (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the six-month period ended 30 June 2025. The Group delivered a 9% year-on-year revenue increase to AED 13.6 billion in H1 2025, driven by broad-based growth across both its Healthcare (Care) and Insurance (Cover) verticals. EBITDA rose 8% year-on-year to AED 2.3 billion in H1-2025, while net profit reached AED 1.03 billion, up 2% year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. The new model strengthens PureHealth's ability to deliver coordinated, value-driven services by aligning care delivery with insurance offerings to streamlining operations across all levels of the health ecosystem. Furthermore, as PureHealth is the only entity in the MENA region which has both healthcare and insurance services under one umbrella, this new streamlined approach gives more transparency and clarity for investors to understand the vertical performance of the group. H.E. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' Financial & Operational Highlights Across Healthcare (Care) and Insurance (Cover) Verticals: The Care Vertical was the largest contributor to revenue during the period, accounting for 72% of the Group's top-line at AED 9.8 billion in revenue, up 7% year-on-year in H1 2025. This growth witnessed across several segments, including Hospitals, Diagnostics, and Technology. Performance in UAE and UK was driven by a 13% increase in outpatient volumes to 4.4 million visits, and a 7% rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5% year-on-year to AED 2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19% year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170% year-on-year to AED 367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14% year-on-year to AED 3.8 billion, supported by an 8% rise in Gross Written Premiums (GWP) to AED 4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6% year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to EBITDA ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid AED 1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt. Strategic Developments PureHealth acquired Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, strengthening its presence in Europe and expanding its specialised care footprint. Closing of the transaction is subject to EU regulatory approvals. Circle Health Group completed the acquisition of Fairfield Independent Hospital in Merseyside, adding inpatient capacity and expanding Circle's footprint in high-demand regions across the UK. Daman has received approvals and licensing to enter the Property & Casualty insurance segment, marking its evolution into a comprehensive, multi-line insurer. It also launched new insurance offerings targeting underpenetrated segments and continued scaling digital claims and onboarding systems. SEHA, through Sheikh Khalifa Medical City (SKMC), signed a strategic partnership with Cincinnati Children's Hospital, one of the top ranked US children's hospital, to advance paediatric clinical services, research, and training in Abu Dhabi. Rafed was appointed as the exclusive distributor for the Unified Purchasing Programme under the Abu Dhabi government mandate, reinforcing its central position in the national procurement ecosystem. OneHealth introduced TurnKey Solutions and Home Dialysis Project, supporting PureHealth's expansion toward home-based care and specialised treatment pathways. Outlook PureHealth is advancing its organic growth strategy through targeted investments in high-margin, complex medical capabilities, the development of clinical centres of excellence, and operational efficiency enhancements enabled by digital health and AI. In parallel, PureHealth continues to expand its international footprint through focused M&A, including the acquisition of Hellenic Healthcare Group (HHG) in Greece and Cyprus. The Group's expansion strategy is supported by a balanced capital allocation framework, combining reinvestment in core strengths with a commitment to shareholder returns. -Ends- About PureHealth: PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 110+ hospitals, 316+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth's network comprises: SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE SEHA CLINICS - Delivering comprehensive community-based healthcare services Daman (The National Insurance Company) – The UAE's leading health insurer The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE Rafed – The UAE's largest healthcare Group Purchasing Organisation PureLab – Managing and operating the largest network of laboratories in the region One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment Ardent Health Services – The fourth largest privately held acute care hospital operator in the US Circle Health Group – The largest independent operators of hospitals in the UK Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care To learn more, please visit
ARN News Center
7 hours ago
- ARN News Center
UAE fuel prices announced for August
Motorists in the UAE will be paying marginally less for petrol in August, the UAE Fuel Price Committee confirmed on Wednesday. Special 95 will be priced at AED2.57 per litre compared to AED 2.58 in July. Meanwhile, Super 98 will drop slightly to AED2.69 per litre from AED 2.70, and E-plus 91 will be AED2.50 per litre from AED 2.51. However, diesel prices will increase to AED2.78 per litre from AED 2.63 in July.
